Drug Delivery System Targeting CD4+ T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Delivery System Targeting CD4+ T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication

Published:2020-10 Issue:10 Volume:109 Page:3013-3020
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Jaimalai Thanapak,Meeroekyai Suthasinee,Suree Nuttee,Prangkio Panchika

Funder

Materials Science Research Center

Chiang Mai University

Thailand Science Research and Innovation

National Research Council of Thailand

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy;Finzi;Science,1997

2. HIV-1 persistence in CD4+ T cells with stem cell-like properties;Buzon;Nat Med,2014

3. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia;Maldarelli;PLoS Pathog,2007

4. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells;Siliciano;Nat Med,2003

5. Re-emergence of HIV after stopping therapy;Chun;Nature,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD4+ T cell-targeting immunoliposomes for treatment of latent HIV reservoir;European Journal of Pharmaceutics and Biopharmaceutics;2024-02

2. THE RELATIONSHIP BETWEEN THE TIME OF USE OF ANTIRETROVIRAL THERAPY (ART) AND THE AMOUNT OF VIRAL LOAD IN ACQUIRED IMMUNODEFICIENCY SYNDROME;International Journal of Applied Pharmaceutics;2023-02-07

3. Nanotechnology: New frontiers in anti-HIV therapy;Nanotechnological Applications in Virology;2022

4. Nanomedicine based approaches for combating viral infections;Journal of Controlled Release;2021-10

5. Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study;Journal of Pharmaceutical Sciences;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3